BioCardia Inc (BCDA)
2.94
+0.18
(+6.52%)
USD |
NASDAQ |
Sep 27, 16:00
2.91
-0.03
(-1.02%)
After-Hours: 20:00
BioCardia SG&A Expense (TTM): 3.965M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 3.965M |
March 31, 2024 | 4.294M |
December 31, 2023 | 4.395M |
September 30, 2023 | 4.378M |
June 30, 2023 | 4.423M |
March 31, 2023 | 4.408M |
December 31, 2022 | 4.419M |
September 30, 2022 | 4.92M |
June 30, 2022 | 5.081M |
March 31, 2022 | 5.111M |
December 31, 2021 | 5.087M |
September 30, 2021 | 4.881M |
June 30, 2021 | 5.00M |
March 31, 2021 | 5.181M |
December 31, 2020 | 5.861M |
September 30, 2020 | 6.185M |
June 30, 2020 | 6.167M |
March 31, 2020 | 6.228M |
December 31, 2019 | 6.002M |
September 30, 2019 | 5.901M |
June 30, 2019 | 5.794M |
March 31, 2019 | 5.681M |
December 31, 2018 | 5.757M |
September 30, 2018 | 6.002M |
June 30, 2018 | 6.041M |
Date | Value |
---|---|
March 31, 2018 | 6.298M |
December 31, 2017 | 6.395M |
September 30, 2017 | 8.301M |
June 30, 2017 | 7.358M |
March 31, 2017 | 5.844M |
December 31, 2016 | 4.108M |
September 30, 2016 | 0.561M |
June 30, 2016 | 0.22M |
March 31, 2016 | 0.205M |
December 31, 2015 | 0.198M |
September 30, 2015 | 0.219M |
June 30, 2015 | 0.235M |
March 31, 2015 | 0.222M |
December 31, 2014 | 0.196M |
September 30, 2014 | 0.216M |
June 30, 2014 | 0.207M |
March 31, 2014 | 0.23M |
December 31, 2013 | 0.259M |
September 30, 2013 | 0.253M |
June 30, 2013 | 0.31M |
March 31, 2013 | 0.396M |
December 31, 2012 | 0.401M |
September 30, 2012 | 0.49M |
June 30, 2012 | 0.498M |
March 31, 2012 | 0.598M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
3.965M
Minimum
Jun 2024
6.228M
Maximum
Mar 2020
5.094M
Average
5.040M
Median
SG&A Expense (TTM) Benchmarks
Alnylam Pharmaceuticals Inc | 856.49M |
Theriva Biologics Inc | 5.633M |
Zevra Therapeutics Inc | 43.01M |
PetIQ Inc | 208.04M |
Instil Bio Inc | 45.94M |